ReCor Medical, ultrasound heart valve therapy company, is proud to announce that it has successfully accomplished the first-in-human procedure using its ultrasound therapy to treat mitral regurgitation (MR). Full details about the study will be presented today at the Transcatheter Cardiovascular Therapeutics (TCT) scientific meeting in Washington, D.C.
Monday, 27 September 2010
ReCor Announces Successful First-In-Human Trial To Treat Mitral Regurgitation Using Ultrasound
ReCor Medical, ultrasound heart valve therapy company, is proud to announce that it has successfully accomplished the first-in-human procedure using its ultrasound therapy to treat mitral regurgitation (MR). Full details about the study will be presented today at the Transcatheter Cardiovascular Therapeutics (TCT) scientific meeting in Washington, D.C.
No comments:
Post a Comment